Showing results (371-380 of 381) with videos related to

Sort By:
Pageof 39
Journal of Medical Genetics|January 7, 2006
Clinical, molecular, and genotype-phenotype correlation studies from 25 cases of oral-facial-digital syndrome type 1: a French and Belgian collaborative studyC Thauvin-Robinet, M Cossée, V Cormier-Daire, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 31, 2009
VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonistL Rihakova, C Quiniou, F F Hamdan, et al.
The Journal of Clinical Investigation|March 17, 2025
Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profilesSvenja Weiss, Hung-Mo Lin, Eric Acosta, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)N Bossard, M Velten, L Remontet, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
Cancer incidence and mortality in France over the period 1978-2000L Remontet, J Estève, A-M Bouvier, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysisStephen A Klassen, Jonathon Senefeld, Patrick W Johnson, et al.
Mayo Clinic Proceedings|May 7, 2021
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysisStephen A Klassen, Jonathon W Senefeld, Patrick W Johnson, et al.
Revue D'Epidemiologie Et De Sante Publique|June 13, 2008
Cancer incidence and mortality in France over the period 1980-2005A Belot, P Grosclaude, N Bossard, et al.
Nature Medicine|September 16, 2020
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control studySean T H Liu, Hung-Mo Lin, Ian Baine, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide studyL Assoumou, C Charpentier, P Recordon-Pinson, et al.
Pageof 39